These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37984785)

  • 1. Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study.
    Averina M; Huber S; Almås B; Brox J; Jacobsen BK; Furberg AS; Grimnes G
    Environ Res; 2024 Feb; 242():117703. PubMed ID: 37984785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to perfluoroalkyl substances (PFAS) and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study.
    Averina M; Brox J; Huber S; Furberg AS
    Environ Res; 2021 Apr; 195():110740. PubMed ID: 33460636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design.
    Kvalem HE; Nygaard UC; Lødrup Carlsen KC; Carlsen KH; Haug LS; Granum B
    Environ Int; 2020 Jan; 134():105259. PubMed ID: 31733527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of prenatal and postnatal exposure to perfluoroalkyl substances with pubertal development and reproductive hormones in females and males: The HOME study.
    Liu Y; Calafat AM; Chen A; Lanphear BP; Jones NY; Cecil KM; Rose SR; Yolton K; Buckley JP; Braun JM
    Sci Total Environ; 2023 Sep; 890():164353. PubMed ID: 37225096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to perfluoroalkyl substances (PFAS) and association with thyroid hormones in adolescent males.
    Freire C; Vela-Soria F; Castiello F; Salamanca-Fernández E; Quesada-Jiménez R; López-Alados MC; Fernandez MF; Olea N
    Int J Hyg Environ Health; 2023 Jul; 252():114219. PubMed ID: 37451108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project.
    Lopez-Espinosa MJ; Mondal D; Armstrong BG; Eskenazi B; Fletcher T
    Environ Health Perspect; 2016 Aug; 124(8):1269-75. PubMed ID: 26794451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluoroalkyl substances in adolescents in northern Norway: Lifestyle and dietary predictors. The Tromsø study, Fit Futures 1.
    Averina M; Brox J; Huber S; Furberg AS
    Environ Int; 2018 May; 114():123-130. PubMed ID: 29500988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Per- and Polyfluoroalkyl Substances and Hormone Levels During the Menopausal Transition.
    Harlow SD; Hood MM; Ding N; Mukherjee B; Calafat AM; Randolph JF; Gold EB; Park SK
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4427-e4437. PubMed ID: 34181018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones.
    Pacyga DC; Papandonatos GD; Rosas L; Whalen J; Smith S; Park JS; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
    Int J Hyg Environ Health; 2024 Jun; 259():114380. PubMed ID: 38657330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.
    Jensen RC; Glintborg D; Timmermann CAG; Nielsen F; Boye H; Madsen JB; Bilenberg N; Grandjean P; Jensen TK; Andersen MS
    Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
    Guo M; Yu Y; Liu H; Zhu C
    Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of per- and polyfluoroalkyl substances with thyroid homeostasis during pregnancy in the SELMA study.
    Derakhshan A; Kortenkamp A; Shu H; Broeren MAC; Lindh CH; Peeters RP; Bornehag CG; Demeneix B; Korevaar TIM
    Environ Int; 2022 Sep; 167():107420. PubMed ID: 35870378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between per- and polyfluoroalkyl substances exposure and thyroid function biomarkers among females attending a fertility clinic.
    Zhang Y; Mustieles V; Korevaar TIM; Martin L; Sun Y; Bibi Z; Torres N; Coburn-Sanderson A; First O; Souter I; Petrozza JC; Broeren MAC; Botelho JC; Calafat AM; Wang YX; Messerlian C
    Environ Pollut; 2024 Apr; 346():123513. PubMed ID: 38350534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
    Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to Perfluoroalkyl Substances during Fetal Life and Pubertal Development in Boys and Girls from the Danish National Birth Cohort.
    Ernst A; Brix N; Lauridsen LLB; Olsen J; Parner ET; Liew Z; Olsen LH; Ramlau-Hansen CH
    Environ Health Perspect; 2019 Jan; 127(1):17004. PubMed ID: 30628845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
    Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.